Patrick J. Mcenany - May 15, 2023 Form 4 Insider Report for CATALYST PHARMACEUTICALS, INC. (CPRX)

Role
President and CEO, Director
Signature
/s/ Patrick J. McEnany
Stock symbol
CPRX
Transactions as of
May 15, 2023
Transactions value $
-$187,978
Form type
4
Date filed
5/17/2023, 05:04 PM
Previous filing
Feb 17, 2023
Next filing
Dec 12, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPRX Common stock, par value $0.001 per share Options Exercise $20.7K +26.2K +0.66% $0.79* 3.97M May 15, 2023 Direct
transaction CPRX Common stock, par value $0.001 per share Sale -$346K -26.2K -0.66% $13.23 3.95M May 15, 2023 Direct F1, F2
transaction CPRX Common stock, par value $0.001 per share Options Exercise $137K +174K +4.41% $0.79* 4.12M May 16, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CPRX Options to purchase common stock Options Exercise $0 -26.2K -0.84% $0.00 3.1M May 15, 2023 Common Stock 26.2K $0.79 Direct F3
transaction CPRX Options to purchase common stock Options Exercise $0 -174K -5.61% $0.00 2.93M May 16, 2023 Common Stock 174K $0.79 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to cover tax withholding requirements.
F2 Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $13.20 to $13.285 per share.
F3 Options vested in two equal tranches beginning on June 15, 2017.